"At the Texas Institute for Kidney and Endocrine Disorders, we do not just want to treat you with medicines. We understand the importance of healthy lifestyles and good nutrition in preventing diseases"

During the past decade, Texas Institute for Kidney and Endocrine Disorders conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Institute for Kidney and Endocrine Disorders" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Texas Institute for Kidney and Endocrine Disorders" are "Chronic Kidney Disease" (2 trials), "Coronary Heart Disease (CHD)" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diabetic Nephropathies" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Texas Institute for Kidney and Endocrine Disorders" in a lesser frequency.

Most popular intervention types in "Texas Institute for Kidney and Endocrine Disorders" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BI 685509" (2 trials), "Canagliflozin 100 mg" (1 trials), "Canagliflozin 300 mg" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Texas Institute for Kidney and Endocrine Disorders" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Texas Institute for Kidney and Endocrine Disorders". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Texas Institute for Kidney and Endocrine Disorders, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Texas Institute for Kidney and Endocrine Disorders, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".